Clinical Trial Update: Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

Clinical trial update indicating that TechnoGenesys, Inc. is recruiting for a Phase 1 study of the ACK1 inhibitor (R)-9b in metastatic castration-resistant pros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• R-9b ACK1 inhibitor (ACK1 inhibitor (R)-9b)

Snippet

Sponsor: TechnoGenesys, Inc. | Conditions: Metastatic Castration-resistant Prostate Cancer (CRPC), Metastatic Castration-resistant Prostate Carcinoma | Phase 1 | Status: RECRUITING